within Pharmacolibrary.Drugs.ATC.D;

model D09AA06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.016666666666666666,
    adminDuration  = 600,
    adminMass      = 0.004,
    adminCount     = 1,
    Vd             = 0.0012,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Triclosan is a broad-spectrum antimicrobial agent historically used in a variety of consumer products including soaps, toothpaste, and cosmetics, as well as in some medical devices. Its use has been limited or banned in many countries due to concerns about safety, resistance, and environmental persistence. It is not approved for systemic therapeutic use.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic values based on limited human pharmacokinetic studies after oral dosing in healthy adults.</p><h4>References</h4><ol><li><p>Duckworth, RM (2013). Pharmacokinetics in the oral cavity: fluoride and other active ingredients. <i>Monographs in oral science</i> 23 125–139. DOI:<a href=&quot;https://doi.org/10.1159/000350590&quot;>10.1159/000350590</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23817065/&quot;>https://pubmed.ncbi.nlm.nih.gov/23817065</a></p></li><li><p>Sandborgh-Englund, G, et al., &amp; Ekstrand, J (2006). Pharmacokinetics of triclosan following oral ingestion in humans. <i>Journal of toxicology and environmental health. Part A</i> 69(20) 1861–1873. DOI:<a href=&quot;https://doi.org/10.1080/15287390600631706&quot;>10.1080/15287390600631706</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16952905/&quot;>https://pubmed.ncbi.nlm.nih.gov/16952905</a></p></li><li><p>Kockisch, S, et al., &amp; Smart, JD (2005). Mucoadhesive, triclosan-loaded polymer microspheres for application to the oral cavity: preparation and controlled release characteristics. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 59(1) 207–216. DOI:<a href=&quot;https://doi.org/10.1016/j.ejpb.2004.07.007&quot;>10.1016/j.ejpb.2004.07.007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15567319/&quot;>https://pubmed.ncbi.nlm.nih.gov/15567319</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D09AA06;
